0I3I Stock Overview
The Cooper Companies, Inc., junto con sus filiales, desarrolla, fabrica y comercializa lentes de contacto.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
0I3I passed our risk checks.
The Cooper Companies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$98.20 |
| 52 Week High | US$103.95 |
| 52 Week Low | US$75.88 |
| Beta | 0.95 |
| 1 Month Change | -3.92% |
| 3 Month Change | 5.98% |
| 1 Year Change | 6.09% |
| 3 Year Change | 1.55% |
| 5 Year Change | 34.58% |
| Change since IPO | 59.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0I3I | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -3.4% | -1.1% | -0.5% |
| 1Y | 6.1% | -2.5% | 0.4% |
Rentabilidad frente al sector: 0I3I superó al sector UK Medical Equipment , que obtuvo un rendimiento del -4.3% el año pasado.
Rentabilidad vs. Mercado: 0I3I superó al mercado UK, que obtuvo un rendimiento del -5.3% el año pasado.
Price Volatility
| 0I3I volatility | |
|---|---|
| 0I3I Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Precio estable de las acciones: 0I3I no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 0I3I (3%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 15,000 | Al White | https://www.coopercos.com |
The Cooper Companies, Inc., junto con sus filiales, desarrolla, fabrica y comercializa lentes de contacto. La empresa opera en dos segmentos, CooperVision y CooperSurgical. El segmento CooperVision ofrece lentes esféricas, que incluyen lentes que corrigen la miopía y la hipermetropía; y lentes tóricas y multifocales, que incluyen lentes que corrigen problemas de visión, como el astigmatismo, la presbicia y la miopía en América, Europa, Oriente Medio, África y Asia-Pacífico.
The Cooper Companies, Inc. Fundamentals Summary
| 0I3I fundamental statistics | |
|---|---|
| Market cap | US$19.60b |
| Earnings (TTM) | US$290.80m |
| Revenue (TTM) | US$3.67b |
67.4x
P/E Ratio5.3x
P/S RatioIs 0I3I overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0I3I income statement (TTM) | |
|---|---|
| Revenue | US$3.67b |
| Cost of Revenue | US$1.24b |
| Gross Profit | US$2.42b |
| Other Expenses | US$2.13b |
| Earnings | US$290.80m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 1.46 |
| Gross Margin | 66.09% |
| Net Profit Margin | 7.93% |
| Debt/Equity Ratio | 36.0% |
How did 0I3I perform over the long term?
See historical performance and comparison